Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 16, 2023; 11(32): 7814-7821
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7814
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7814
Table 3 Secondary outcomes
| Outcome | Aspirin group (n = 30) | No aspirin group (n = 30) | P value |
| mRS score at 90 d, median (IQR) | 2 (1-3) | 3 (2-4) | 0.04 |
| Bleeding complications, n (%) | 2 (6.7) | 2 (6.7) | 1.00 |
| Intracranial hemorrhage, n (%) | 0 (0) | 0 (0) | - |
| Gastrointestinal bleeding, n (%) | 0 (0) | 0 (0) | - |
| Other major bleeding, n (%) | 2 (6.7) | 2 (6.7) | - |
| Mortality rate, n (%) | 3 (10) | 4 (13.3) | 0.69 |
- Citation: Zhang JQ, Pan ZB. Efficacy and safety of aspirin antiplatelet therapy within 48 h of symptom onset in patients with acute stroke. World J Clin Cases 2023; 11(32): 7814-7821
- URL: https://www.wjgnet.com/2307-8960/full/v11/i32/7814.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i32.7814